The FDA has approved several blood tests measuring p-tau and amyloid to assist diagnosis of Alzheimer's in symptomatic adults. These tests, including Lumipulse, Elecsys, and PrecivityAD2, aid evaluation alongside clinical exams and imaging but are not approved for screening asymptomatic people. Providers recommend testing only when results would influence care and after other causes are excluded.
